Phosphorylation of cytidine, deoxycytidine, and their analog monophosphates by human UMP/CMP kinase is differentially regulated by ATP and magnesium

Molecular Pharmacology

Volumn 67, Issue 3, 2005, Pages 806-814

  Hsu, Chih Hung ^a,b   Liou, Jieh Yuan ^c   Dutschman, Ginger E ^a   Cheng, Yung Chi ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTIDINE; CYTIDINE PHOSPHATE; DEOXYCYTIDINE; DEOXYURIDINE PHOSPHATE; FLOXURIDINE PHOSPHATE; MAGNESIUM; PYRIMIDINE; PYRIMIDINE NUCLEOSIDE; RECOMBINANT ENZYME; URIDINE PHOSPHATE;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADENOSINE TRIPHOSPHATE; CYTIDINE; CYTIDINE MONOPHOSPHATE; DEOXYCYTIDINE; DEOXYCYTIDINE MONOPHOSPHATE; HUMANS; KINETICS; NUCLEOSIDE-PHOSPHATE KINASE; PHOSPHORYLATION; SUBSTRATE SPECIFICITY;

EID: 14944366413     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.006098     Document Type: Article

References (39)

1. Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, and Bertino JR (2002) Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 1587:164-173.
2. Bertrand T, Briozzo P, Assairi L, Ofiteru A, Bucurenci N, Munier-Lehmann H, Golinelli-Pimpaneau B, Barzu O, and Gilles AM (2002) Sugar specificity of bacterial CMP kinases as revealed by crystal structures and mutagenesis of Escherichia coli enzyme. J Mol Biol 315:1099-1110.
3. Briozzo P, Golinelli-Pimpaneau B, Gilles AM, Gaucher JF, Burlacu-Miron S, Sakamoto H, Janin J, and Barzu O (1998) Structures of Escherichia coli CMP kinase alone and in complex with CDP: a new fold of the nucleoside monophosphate binding domain and insights into cytosine nucleotide specificity. Structure 6:1517-1527.
4. Bucurenci N, Sakamoto H, Briozzo P, Palibroda N, Serina L, Sarfati RS, Labesse G, Briand G, Danchin A, Barzu O, et al. (1996) CMP kinase from Escherichia coli is structurally related to other nucleoside monophosphate kinases. J Biol Chem 271:2856-2862.
5. Cheng YC (2001) Potential use of antiviral L(-)nucleoside analogues for the prevention or treatment of viral associated cancers. Cancer Lett 162 (Suppl):S33-S37.
6. Cheng YC and Prusoff WH (1974) A new rapid assay for measuring deoxycytidylate-and deoxythymidylate-kinase activities. Anal Biochem 60:545-550.
7. Galmarini CM, Mackey JR, and Dumontet C (2001) Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia 15:875-890.
8. Galmarini CM, Mackey JR, and Dumontet C (2002) Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol 3:415-424.
9. Grant S (1998) Ara-C: cellular and molecular pharmacology. Adv Cancer Res 72: 197-233.
10. Grove KL and Cheng YC (1996) Uptake and metabolism of the new anticancer compound beta-L-(-)-dioxolane-cytidine in human prostate carcinoma DU-145 cells. Cancer Res 56:4187-4191.
11. Grove KL, Guo X, Liu SH, Gao Z, Chu CK, and Cheng YC (1995) Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration. Cancer Res 55:3008-3011.
12. Hande KR and Chabner BA (1978) Pyrimidine nucleoside monophosphate kinase from human leukemic blast cells. Cancer Res 38:579-585.
13. Hui YF and Reitz J (1997) Gemcitabine: a cytidine analogue active against solid tumors. Am J Health Syst Pharm 54:162-170.
14. Hutter MC and Helms V (2000) Phosphoryl transfer by a concerted reaction mechanism in UMP/CMP-kinase. Protein Sci 9:2225-2231.
15. Krishnan P, Fu Q, Lam W, Liou JY, Dutschman G, and Cheng YC (2002) Phosphorylation of pyrimidine deoxynucleoside analog diphosphates: selective phosphorylation of L-nucleoside analog diphosphates by 3-phosphoglycerate kinase. J Biol Chem 277:5453-5459.
16. Liljelund P and Lacroute F (1986) Genetic characterization and isolation of the Saccharomyces cerevisiae gene coding for uridine monophosphokinase. Mol Gen Genet 205:74-81.
17. Liou JY, Dutschman GE, Lam W, Jiang Z, and Cheng YC (2002) Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates. Cancer Res 62:1624-1631.
18. Maness P and Orengo A (1976) Activation of rat liver pyrimidine nucleoside monophosphate kinase. Biochim Biophys Acta 429:182-190.
19. Muller-Dieckmann HJ and Schulz GE (1994) The structure of uridylate kinase with its substrates, showing the transition state geometry. J Mol Biol 236:361-367.
20. Muller-Dieckmann HJ and Schulz GE (1995) Substrate specificity and assembly of the catalytic center derived from two structures of ligated uridylate kinase. J Mol Biol 246:522-530.
21. Noble S and Goa KL (1997) Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. Drugs 54:447-472.
22. Ostermann N, Schlichting I, Brundiers R, Konrad M, Reinstein J, Veit T, Goody RS, and Lavie A (2000) Insights into the phosphoryltransfer mechanism of human thymidylate kinase gained from crystal structures of enzyme complexes along the reaction coordinate. Structure 8:629-642.
23. Pasti C, Gallois-Montbrun S, Munier-Lehmann H, Veron M, Gilles AM, and Deville-Bonne D (2003) Reaction of human UMP-CMP kinase with natural and analog substrates. Eur J Biochem 270:1784-1790.
24. Pearman AT, Castro-Faria-Neto HC, McIntyre TM, Prescott SM, and Stafforini DM (2001) Characterization of human UMP-CMP kinase enzymatic activity and 5′ untranslated region. Life Sci 69:2361-2370.
25. Ruth JL and Cheng YC (1981) Nucleoside analogues with clinical potential in antivirus chemotherapy. The effect of several thymidine and 2′-deoxycytidine analogue 5′-triphosphates on purified human (α,β) and herpes simplex virus (types 1, 2) DNA polymerases. Mol Pharmacol 20:415-422.
26. Sabini E, Ort S, Monnerjahn C, Konrad M, and Lavie A (2003) Structure of human dCK suggests strategies to improve anticancer and antiviral therapy. Nat Struct Biol 10:513-519.
27. 2+ at 2.2 A: implications for water-mediated specificity. Biochemistry 35:9716-9727.
28. Scott EM and Wright RC (1979) Kinetics and equilibria of pyrimidine nucleoside monophosphate kinase from human erythrocytes. Biochim Biophys Acta 571:45-54.
29. Serina L, Blondin C, Krin E, Sismeiro O, Danchin A, Sakamoto H, Gilles AM, and Barzu O (1995) Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP. Biochemistry 34:5066-5074.
30. Teng YS, Chen SH, and Scott K (1976) Human erythrocyte pyrimidine nucleoside monophosphate kinase. Partial purification and properties of two allelic gene products. J Biol Chem 251:4179-4183.
31. Townsley CA, Chi K, Ernst DS, Belanger K, Tannock I, Bjarnason GA, Stewart D, Goel K, Ruether JD, Siu LL, et al. (2003) Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group. J Clin Oncol 21:1524-1529.
32. Traut TW (1994a) Dissociation of enzyme oligomers: a mechanism for allosteric regulation. Crit Rev Biochem Mol Biol 29:125-163.
33. Traut TW (1994b) Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140:1-22.
34. Van Rompay AR, Johansson M, and Karlsson A (1999) Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: molecular characterization of the human enzyme. Mol Pharmacol 56:562-569.
35. Van Rompay AR, Johansson M, and Karlsson A (2000) Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases. Pharmacol Ther 87:189-198.
36. Weitman S, Marty J, Jolivet J, Locas C, and Von Hoff DD (2000) The new dioxolane, (-)-2′-deoxy-3′-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts. Clin Cancer Res 6:1574-1578.
37. Wiesmuller L, Scheffzek K, Kliche W, Goody RS, Wittinghofer A, and Reinstein J (1995) Crystallization and preliminary X-ray analysis of UMP/CMP-kinase from Dictyostelium discoideum with the specific bisubstrate inhibitor P1-(adenosine 5′)-P5-(uridine 5′)-pentaphosphate (UP5A). FEBS Lett 363:22-24.
38. Yan H and Tsai MD (1999) Nucleoside monophosphate kinases: structure, mechanism and substrate specificity. Adv Enzymol Relat Areas Mol Biol 73:103-134.
39. Yu L, Mack J, Hajduk PJ, Kakavas SJ, Saiki AY, Lerner CG, and Olejniczak ET (2003) Solution structure and function of an essential CMP kinase of Streptococcus pneumoniae. Protein Sci 12:2613-2621.